# Effectiveness and Safety of Desloratadine in Patients With Allergic Airway Disease During the Pollen Season (Study P03284)

> **NCT00779636** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 506 (actual)

## Conditions studied

- Allergic Airway Disease

## Interventions

- **DRUG:** Desloratadine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00779636
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07-01
- **Primary completion:** 2004-11-01
- **Final completion:** 2004-11-01
- **Target enrollment:** 506 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00779636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00779636, "Effectiveness and Safety of Desloratadine in Patients With Allergic Airway Disease During the Pollen Season (Study P03284)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00779636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*